INMIS 2027 will bring global stakeholders together to share up-to-date information on key areas in maternal and neonatal immunization. This major symposium provides the opportunity for stakeholders from the entire spectrum of vaccinology research — laboratory science and clinical trials through to implementation and the social science of immunization programs — to share the latest progress. Accepted abstracts will be assigned to either oral podium or oral e-poster presentation.
Abstracts describing maternal and neonatal immunization research and implementation will be evaluated according to the following themes:
Authors who submitted an abstract can follow its status through their user account in the online submission system. That account is NOT a registration for the conference — it was used only for abstract submission.
The call for abstracts closed on Monday, September 28, 2026 (11:59 p.m. Adelaide time, GMT +10:30). Submissions are no longer accepted.
Disclosure of all financial relationships that the author(s) have with the manufacturer or supplier of any commercial products or services related to the work must be indicated on the abstract submission form. All abstracts will be reviewed via the same process irrespective of these disclosures.
INMIS 2027, with assistance from the Gates Foundation and other sponsors, will provide funding for travel bursaries to presenting authors who reside and are conducting research in low and lower middle income countries (LMICs) as per the World Bank status.
Abstracts are to be submitted in English and should not exceed 300 words, excluding title and authors. They must include introduction/background & aims, methods, results and conclusions. Figures and tables do not count against the word count.